Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1 Methyl 3 Isobutylxanthine
2. 1-methyl-3-isobutylxanthine
3. 3 Isobutyl 1 Methylxanthine
4. Ibmx
5. Isobutyltheophylline
1. Ibmx
2. 28822-58-4
3. Isobutylmethylxanthine
4. 1-methyl-3-isobutylxanthine
5. Methylisobutylxanthine
6. 3-isobutyl-1-methylxanthine (ibmx)
7. 1h-purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-
8. Xanthine, 3-isobutyl-1-methyl-
9. 3-isobutyl-1-methyl-1h-purine-2,6(3h,7h)-dione
10. 3-isobutyl-1-methyxanthine
11. 1-methyl-3-(2-methylpropyl)-7h-purine-2,6-dione
12. 3-isobutyl-1-methyl-3,9-dihydro-1h-purine-2,6-dione
13. 3-isobutyl-1-methyl-7h-xanthine
14. 3,7-dihydro-3-isobutyl-1-methyl-1h-purine-2,6-dione
15. Nsc 165960
16. Chebi:34795
17. C10h14n4o2
18. 3-isobutyl-1-methyl-3,7-dihydro-1h-purine-2,6-dione
19. 2-acetoxy-benzoic Acid
20. 3-isobutyl-methylxanthine
21. Nsc165960
22. 1-methyl-3-(2-methylpropyl)-3,7-dihydro-1h-purine-2,6-dione
23. 3-isobutyl-1-methyl-xanthine
24. Chembl275084
25. Tbt296u68m
26. Nsc-165960
27. Sc 2964
28. 1-methyl-3-(2-methylpropyl)-3,9-dihydro-1h-purine-2,6-dione
29. 3,7-dihydro-1-methyl-3-(2-methylpropyl)-1h-purine-2,6-dione
30. Methyl-isobutylxanthine
31. 3-isobutyl 1-methylxanthine
32. Smr000326697
33. Ccris 4290
34. Sr-01000075185
35. Einecs 249-259-3
36. Mfcd00005584
37. Unii-tbt296u68m
38. 1zkl
39. 1zkn
40. 3ecn
41. 3itu
42. 3jwr
43. 2hd1
44. 2r8q
45. 3qi4
46. Spectrum2_001705
47. Spectrum2_001735
48. Spectrum3_001958
49. Spectrum4_001052
50. Spectrum5_001856
51. Lopac-i-5879
52. Molmap_000030
53. 3-isobutyl-1-methylanxthine
54. Lopac0_000642
55. Oprea1_135287
56. Oprea1_228781
57. Schembl50315
58. 3-isobutyl-1-methylxantliine
59. Bspbio_001153
60. Bspbio_003558
61. Gtpl388
62. Kbiogr_000493
63. Kbiogr_001344
64. Kbiogr_002566
65. Kbioss_000493
66. Kbioss_002575
67. 1-methyl-3-isobutyl-xanthine
68. Mls001056732
69. Mls001066424
70. Divk1c_000922
71. Spectrum1505298
72. Spectrum2300204
73. Spbio_001690
74. Spbio_001810
75. Dtxsid0040549
76. Bcbcmap01_000110
77. Bdbm15336
78. Chebi:43253
79. Hms502o04
80. Kbio1_000922
81. Kbio2_000493
82. Kbio2_002566
83. Kbio2_003061
84. Kbio2_005134
85. Kbio2_005629
86. Kbio2_007702
87. Kbio3_000905
88. Kbio3_000906
89. Kbio3_002878
90. Kbio3_003044
91. 3-isobutyl-1-methyl-9h-xanthine
92. Cmap_000087
93. Ninds_000922
94. 1-methyl-3-(2-methylpropyl)-1,3,7-trihydropurine-2,6-dione
95. Bio1_000456
96. Bio1_000945
97. Bio1_001434
98. Bio2_000407
99. Bio2_000887
100. Hms1362i15
101. Hms1792i15
102. Hms1990i15
103. Hms2090j10
104. Hms2231c11
105. Hms3262a05
106. Hms3369e16
107. Hms3403i15
108. Hms3604d14
109. Hms3648o18
110. Albb-024315
111. Bcp13248
112. Zinc3861807
113. Tox21_500642
114. 3-isobuthyl-1-methylxanthine
115. Bdbm50027176
116. Ccg-39513
117. Ccg-39624
118. Hsci1_000261
119. Pdsp1_000324
120. Pdsp2_000322
121. S5836
122. Stl558248
123. Akos003390599
124. Akos015903085
125. Cs-3361
126. Db07954
127. Lp00642
128. Sc-2964
129. Sdccgsbi-0050622.p003
130. Idi1_000922
131. Idi1_002162
132. Ncgc00015559-01
133. Ncgc00015559-02
134. Ncgc00015559-03
135. Ncgc00015559-04
136. Ncgc00015559-05
137. Ncgc00015559-06
138. Ncgc00015559-07
139. Ncgc00015559-08
140. Ncgc00015559-09
141. Ncgc00015559-10
142. Ncgc00015559-11
143. Ncgc00015559-21
144. Ncgc00094009-01
145. Ncgc00094009-02
146. Ncgc00094009-03
147. Ncgc00094009-04
148. Ncgc00094009-05
149. Ncgc00094009-06
150. Ncgc00261327-01
151. Xanthine, 1-methyl-3-(2-methylpropyl)
152. As-71134
153. Bi164529
154. Hy-12318
155. Ibmx(nsc165960; Sc2964)
156. 3-isobutyl-1-methyl-7h-purine-2,6-dione
157. Db-047466
158. [eur J Pharmacol 170: 35 (1989)]
159. B7206
160. Eu-0100642
161. Ft-0615920
162. Wln: T56 Bm Dn Fnvnvj F1y1&1 H1
163. D71221
164. I 5879
165. 3-isobutyl-1-methylxanthine, Bioultra, >=99%
166. 822i584
167. A876607
168. L001156
169. Q223093
170. 3-isobutyl-1-methylxanthine - Cas 28822-58-4
171. J-640140
172. J-800144
173. Sr-01000075185-1
174. Sr-01000075185-6
175. 3-isobutyl-1-methylxanthine, >=99% (hplc), Powder
176. Brd-k94979336-001-06-9
177. Brd-k94979336-001-09-3
178. 1h-purine-2, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-
179. Imx;isobutylmethylxanthine;methylisobutylxanthine;nsc165960;sc2964
180. 1-methyl-3-(2-methylpropyl)-2,3,6,7-tetrahydro-1h-purine-2,6-dione
181. 1-methyl-3-(2-methylpropyl)-2,3,6,9-tetrahydro-1h-purine-2,6-dione
| Molecular Weight | 222.24 g/mol |
|---|---|
| Molecular Formula | C10H14N4O2 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 222.11167570 g/mol |
| Monoisotopic Mass | 222.11167570 g/mol |
| Topological Polar Surface Area | 69.3 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 318 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Phosphodiesterase Inhibitors
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Isobutylmethylxanthine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isobutylmethylxanthine, including repackagers and relabelers. The FDA regulates Isobutylmethylxanthine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isobutylmethylxanthine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Isobutylmethylxanthine supplier is an individual or a company that provides Isobutylmethylxanthine active pharmaceutical ingredient (API) or Isobutylmethylxanthine finished formulations upon request. The Isobutylmethylxanthine suppliers may include Isobutylmethylxanthine API manufacturers, exporters, distributors and traders.
click here to find a list of Isobutylmethylxanthine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Isobutylmethylxanthine DMF (Drug Master File) is a document detailing the whole manufacturing process of Isobutylmethylxanthine active pharmaceutical ingredient (API) in detail. Different forms of Isobutylmethylxanthine DMFs exist exist since differing nations have different regulations, such as Isobutylmethylxanthine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Isobutylmethylxanthine DMF submitted to regulatory agencies in the US is known as a USDMF. Isobutylmethylxanthine USDMF includes data on Isobutylmethylxanthine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Isobutylmethylxanthine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Isobutylmethylxanthine suppliers with USDMF on PharmaCompass.
Isobutylmethylxanthine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Isobutylmethylxanthine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Isobutylmethylxanthine GMP manufacturer or Isobutylmethylxanthine GMP API supplier for your needs.
A Isobutylmethylxanthine CoA (Certificate of Analysis) is a formal document that attests to Isobutylmethylxanthine's compliance with Isobutylmethylxanthine specifications and serves as a tool for batch-level quality control.
Isobutylmethylxanthine CoA mostly includes findings from lab analyses of a specific batch. For each Isobutylmethylxanthine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Isobutylmethylxanthine may be tested according to a variety of international standards, such as European Pharmacopoeia (Isobutylmethylxanthine EP), Isobutylmethylxanthine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Isobutylmethylxanthine USP).
LOOKING FOR A SUPPLIER?
